Last $3.98 USD
Change Today +0.20 / 5.29%
Volume 373.3K
AGEN On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 06/19/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kerry A. Wentworth

Vice President of Clinical Regulatory & Quality, Agenus Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

39$824,366
As of Fiscal Year 2012

Background*

Ms. Kerry A. Wentworth serves as the Vice President of Clinical Regulatory & Quality at Agenus Inc. Prior to that, Ms. Wentworth served as Vice President of Regulatory Affairs & Clinical Operations of Antigenics Inc. Ms. Wentworth joined Antigenics in 2005 and previously served as Senior Director of Regulatory Affairs at Genelabs Technologies, where she was responsible for regulatory and quality functions. Prior to Genelabs, Ms. Wentworth held various positions in regulatory ...

Read Full Background

Corporate Headquarters*

3 Forbes Road
Lexington, Massachusetts 02421-7305

United States

Phone: 781-674-4400
Fax: 781-674-4200

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
The University of New Hampshire, Durham

Other Affiliations*

Annual Compensation*

Salary$260,762
Total Annual Compensation$260,762

Stock Options*

Restricted Stock Awards$189,197
All Other Compensation$7,938
Exercisable Options134,950
Exercisable Options Value$17,026
Unexercisable Options94,099
Unexercisable Options Value$12,329
Total Value of Options$29,355
Total Number of Options229,049

Total Compensation*

Total Annual Cash Compensation$309,478
Total Short Term Compensation$260,762
Other Long Term Compensation$197,135
Total Calculated Compensation$824,366
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGEN:US $3.98 USD +0.20

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
J. Joseph Kim Ph.D.Chief Executive Officer, President and Director
Inovio Pharmaceuticals, Inc.
$757.0K
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$864.8K
Christopher Nishan Garabedian Chief Executive Officer, President and Director
Sarepta Therapeutics, Inc.
$490.0K
Mark R. Baker J.D.Chief Executive Officer, Director, Member of Science & Technology Committee and Member of Strategy & External Technology Subcommittee
Progenics Pharmaceuticals, Inc.
$672.8K
Stephen M. Simes Vice Chairman, Chief Executive Officer and President
BioSante Pharmaceuticals, Inc.
$496.7K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AGENUS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.